polyethylene glycol

also known as polyethylene glycol 3350 · PEG · PEG 3350 · Golytely · MiraLAX · NER1006 · Macrogol 3350 · Movicol · +31 more

Other / unclassified

Developed for: constipation disorder · colorectal carcinoma · adenoma · cystic fibrosis · hepatic encephalopathy · intestinal disorder · irritable bowel syndrome · liver disorder
+25 more
· nervous system injury · peripheral nerve lesion · polyp of colon · anastomosing haemangioma · anus disorder · colonic disorder · escherichia coli infection · hemolytic-uremic syndrome · infectious colitis · inflammatory bowel disease · intestinal impaction · intestinal infectious disease · Klebsiella pneumonia · Parkinson disease · poisoning · sarcoma · BD syndrome · dry eye syndrome · enuresis · intestinal dysmotility syndrome · malignant colon neoplasm · nocturnal enuresis · opioid-induced constipation · outlet dysfunction constipation · ulcer of anus and rectum
Investigated by: Norgine · Braintree Laboratories · Shandong University · Changhai Hospital · 900th Hospital of PLA Joint Logistic Support Force · Affiliated Hospital of Southwest Medical University
+125 more
· Affiliated Yueqing Hospital of Wenzhou Medical University · Bayer · Daping Hospital of Army Medical University · Gastroenterology Services, Ltd. · Kyungpook National University Hospital · Mexican Social Security Institute · National Cancer Institute (NCI) · The First Affiliated Hospital of Nanchang University · The Second Hospital of Hebei Medical University · Vanderbilt University Medical Center · Affiliated Hospital of Qinghai University · Afﬁliated Hospital of North Sichuan Medical College · Aga Khan University · Agency for Healthcare Research and Quality (AHRQ) · Air Force Military Medical University, China · Alfasigma S.p.A. · Assistance Publique - Hôpitaux de Paris · Bausch Health Americas, Inc. · Beijing Tsinghua Chang Gung Hospital · Boston Medical Center · Catholic Kwandong University · Cedars-Sinai Medical Center · Centro Hospitalar Lisboa Ocidental · Chad R. Tracy · Corporacion Parc Tauli · Dark Canyon Laboratories, LLC · Department of Medical Services Ministry of Public Health of Thailand · Evergreen General Hospital, Taiwan · Faculty of Medicine, University of Indonesia · First Affiliated Hospital Xi'an Jiaotong University · Fu Jen Catholic University Hospital · Fundación Canaria Rafael Clavijo para la Investigación Biomédica · Hadassah Medical Organization · Haifeng Lan · Hanyang University · Helsinki University Central Hospital · Hospital Civil de Guadalajara · Hospital Universitario de Canarias · Hospital de Clínicas Dr. Manuel Quintela · Huizhou Municipal Central Hospital · Ikazia Hospital, Rotterdam · Incheon St.Mary's Hospital · Indiana University · Istituto Clinico Humanitas · Jennifer Afton Cooper MD · Jiangmen Central Hospital · Kangbuk Samsung Hospital · Karolinska Institutet · Katherine Smith MD · Kyunghee University Medical Center · LiuZhou People's Hospital · Lund University · M.D. Anderson Cancer Center · Maastricht University Medical Center · McGill University Health Centre/Research Institute of the McGill University Health Centre · Michael Sprague MD · National Cancer Center, Korea · National Institute of Medical Sciences and Nutrition Salvador Zubiran · Neuraptive Therapeutics Inc. · Ningjin People's Hospital · Ningxia Medical University General Hospital · Northwell Health · Nova Scotia Health Authority · Novartis · Odense University Hospital · Oregon Health and Science University · Ospedale San Pio · Ottawa Hospital Research Institute · PT Meiji Indonesia · Pamela Frazzini-Padilla MD · Pierrel Research Europe GmbH · Post Graduate Institute of Medical Education and Research, Chandigarh · Qianfoshan Hospital · Qilu Hospital of Shandong University · all 131 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Label expansion	US (FDA)	MIRALAX	—	2009-03-13	fda.gov ↗
Approved	US (FDA)	GOLYTELY	—	1984-07-13	fda.gov ↗

Trials 105 · started per year

today

US approved 1984

198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 01 trial
Phase 0	NCT07700277	Aug 2026 → Aug 2027 expected	intestinal disorder	Ottawa Hospital Research Institute	Not yet recruiting	No outcome recorded
Phase 16 trials
Phase 1	NCT02359825	Sep 2019 → May 2026	peripheral nerve lesion	Vanderbilt University Medical Center	Completed	No outcome recorded
Phase 1	NCT04730245	Jun 2018 → Mar 2020	Parkinson disease	Torre Médica Santé	Completed	No outcome recorded
Phase 1	NCT03236064	May 2016 → May 2024	nervous system injury	WellSpan Health	Unknown	No outcome recorded
Phase 1	NCT02254629	Jul 2014 → Aug 2015	irritable bowel syndrome	Shandong University	Completed	No outcome recorded
Phase 1	NCT01834742	Apr → Sep 2011	colorectal cancer	Norgine	Completed	No outcome recorded
Phase 1	NCT00868985	Jan → Aug 2008	constipation disorder	Norgine	Completed	No outcome recorded
Phase 1/22 trials
Phase 1/2	NCT04270019	Jun 2020 → Sep 2023	nervous system injury, peripheral nerve lesion	Nova Scotia Health Authority	Withdrawn	No outcome recorded
Phase 1/2	NCT00722410	Sep 2008 → Sep 2010	Klebsiella pneumonia	Hadassah Medical Organization	Unknown	No outcome recorded
Phase 210 trials
Phase 2	NCT07201311	Jun 2026 → Jun 2028 expected	poisoning	Assistance Publique - Hôpitaux de Paris	Recruiting	No outcome recorded
Phase 2	NCT04458129	Sep 2020 → Apr 2022	cystic fibrosis	University Hospital, Bordeaux	Terminated	No outcome recorded
Phase 2	NCT03332485	Nov 2017 → Mar 2018	—	Sebela Pharmaceuticals Development LLC	Completed	No outcome recorded
Phase 2	NCT02910440	Jan → Nov 2017	—	Dark Canyon Laboratories, LLC	Completed	No outcome recorded
Phase 2	NCT02979223	Nov 2016 → Jun 2017	—	National Cancer Center, Korea	Completed	No outcome recorded
Phase 2	NCT01714466	Oct 2012 → Jul 2013	colon carcinoma	Norgine	Completed	No outcome recorded
Phase 2	NCT01212445	Oct 2010 → Nov 2011	constipation disorder	Bayer	Completed	No outcome recorded
Phase 2	NCT01044394	Jan 2010 → Jun 2011	—	Boston Medical Center	Withdrawn	No outcome recorded
Phase 2	NCT00828984	Oct 2009 → Oct 2014	adenoma, colorectal carcinoma	National Cancer Institute (NCI)	Completed	No outcome recorded
Phase 2	NCT00403858	Oct 2000 → Apr 2002	intestinal impaction	Norgine	Completed	No outcome recorded
Phase 2/31 trial
Phase 2/3	NCT05897086	Aug 2023 → Dec 2028 expected	—	Vanderbilt University Medical Center	Enrolling by invitation	No outcome recorded
Phase 318 trials
Phase 3	NCT05726097	Feb → Oct 2023	colorectal cancer, inflammatory bowel disease, polyp of colon	Region Skane	Completed	No outcome recorded
Phase 3	NCT05870553	Jan → May 2023	—	Taejoon Pharmaceutical Co., Ltd.	Completed	No outcome recorded
Phase 3	NCT05076799	Sep 2021 → Nov 2022	—	Sichuan University	Completed	No outcome recorded
Phase 3	NCT03957668	Dec 2019 → Sep 2020	constipation disorder	Faculty of Medicine, University of Indonesia	Unknown	No outcome recorded
Phase 3	NCT03315949	May 2017 → Feb 2018	—	Incheon St.Mary's Hospital	Completed	No outcome recorded
Phase 3	NCT03106922	Apr 2016 → Jul 2020	—	Alfasigma S.p.A.	Unknown	No outcome recorded
Phase 3	NCT02292459	Dec 2015	constipation disorder	Bayer	Withdrawn	No outcome recorded
Phase 3	NCT02540031	Sep 2015 → Apr 2018	—	Kyungpook National University Hospital	Completed	No outcome recorded
Phase 3	NCT02273141	Nov 2014 → Aug 2015	colorectal carcinoma	Norgine	Completed	No outcome recorded
Phase 3	NCT02273167	Oct 2014 → Aug 2015	colorectal carcinoma	Norgine	Completed	No outcome recorded
Phase 3	NCT02254486	Sep 2014 → Jun 2015	colon carcinoma	Norgine	Completed	No outcome recorded
Phase 3	NCT02731963	Sep 2014 → Feb 2015	anastomosing haemangioma	Mexican Social Security Institute	Completed	No outcome recorded
Phase 3	NCT01929590	Oct 2011 → Jun 2012	—	National Institute of Medical Sciences and Nutrition Salvador Zubiran	Completed	No outcome recorded
Phase 3	NCT01251822	Nov 2010 → Sep 2011	constipation disorder	Norgine	Completed	No outcome recorded
Phase 3	NCT00503815	Jul → Nov 2007	—	Braintree Laboratories	Completed	No outcome recorded
Phase 3	NCT00503607	Jul → Nov 2007	—	Braintree Laboratories	Completed	No outcome recorded
Phase 3	NCT00403819	Apr 2002 → Apr 2003	constipation disorder	Norgine	Completed	No outcome recorded
Phase 3	NCT00403897	Aug 2001 → Jan 2003	constipation disorder	Norgine	Completed	No outcome recorded

Phase 439 trials
Phase 4	NCT06748638	Sep 2024 → Oct 2025 overdue	—	Haifeng Lan	Enrolling by invitation	No outcome recorded
Phase 4	NCT06666556	Jul 2024 → Jul 2025 overdue	colorectal cancer	Hospital Civil de Guadalajara	Recruiting	No outcome recorded
Phase 4	NCT06159777	Jun 2024 → Mar 2026	constipation disorder, pelvic organ prolapse	University Hospitals Cleveland Medical Center	Completed	No outcome recorded
Phase 4	NCT05821309	Jun 2023 → Jul 2026 overdue	constipation disorder	Indiana University	Recruiting	No outcome recorded
Phase 4	NCT05805436	Jun 2023 → Mar 2026 overdue	constipation disorder, kidney cancer, prostate cancer	Chad R. Tracy	Recruiting	No outcome recorded
Phase 4	NCT05054036	Jan 2022 → Jul 2024	—	Yale University	Completed	No outcome recorded
Phase 4	NCT04708366	Feb 2021 → Mar 2022	colonic disorder	University of Bologna	Unknown	No outcome recorded
Phase 4	NCT04585542	Oct 2020 → Jan 2025	—	University of California, Irvine	Terminated	No outcome recorded
Phase 4	NCT04436601	Mar 2020 → Dec 2023	hepatic encephalopathy	Aga Khan University	Unknown	No outcome recorded
Phase 4	NCT04210427	Dec 2019 → Jun 2023	cystic fibrosis	St. Louis University	Completed	No outcome recorded
Phase 4	NCT04197869	Dec 2019 → Jun 2023	constipation disorder	Northwell Health	Completed	No outcome recorded
Phase 4	NCT04138004	Dec 2019 → Jun 2021	—	Department of Medical Services Ministry of Public Health of Thailand	Completed	No outcome recorded
Phase 4	NCT04263896	Aug 2019 → Jun 2024	constipation disorder	University of Chicago	Completed	No outcome recorded
Phase 4	NCT03830489	Feb → Oct 2019	—	Hospital Universitario de Canarias	Completed	No outcome recorded
Phase 4	NCT03800745	Nov 2018 → May 2020	—	The Cleveland Clinic	Completed	No outcome recorded
Phase 4	NCT03742232	Oct 2018 → Mar 2020	colon adenoma, polyp of colon	Istituto Clinico Humanitas	Completed	No outcome recorded
Phase 4	NCT03738904	Oct 2018 → Aug 2022	anus disorder	Cedars-Sinai Medical Center	Completed	No outcome recorded
Phase 4	NCT03987893	May 2018 → May 2020	hepatic encephalopathy, liver disorder	Post Graduate Institute of Medical Education and Research, Chandigarh	Unknown	No outcome recorded
Phase 4	NCT03356015	Dec 2017 → Jan 2018	adenoma	Changhai Hospital	Unknown	No outcome recorded
Phase 4	NCT02652637	Mar 2016 → Sep 2018	—	Helsinki University Central Hospital	Unknown	No outcome recorded
Phase 4	NCT02119000	Aug 2015 → Jan 2020	—	McGill University Health Centre/Research Institute of the McGill University Health Centre	Terminated	No outcome recorded
Phase 4	NCT02396017	Mar → May 2015	—	Centro Hospitalar Lisboa Ocidental	Unknown	No outcome recorded
Phase 4	NCT02290093	Nov 2014 → Sep 2015	—	Kyunghee University Medical Center	Completed	No outcome recorded
Phase 4	NCT02073552	May 2014 → Dec 2015	—	Fundación Canaria Rafael Clavijo para la Investigación Biomédica	Completed	No outcome recorded
Phase 4	NCT02070341	Feb → Jul 2014	—	Queen's University	Terminated	No outcome recorded
Phase 4	NCT01853709	May → Dec 2013	—	Corporacion Parc Tauli	Unknown	No outcome recorded
Phase 4	NCT01719653	Oct 2012 → Sep 2014	—	Gastroenterology Services, Ltd.	Completed	No outcome recorded
Phase 4	NCT01429779	Jul 2012 → Oct 2014	liver disorder	Maastricht University Medical Center	Unknown	No outcome recorded
Phase 4	NCT01622972	Sep 2011 → Feb 2014	constipation disorder, irritable bowel syndrome	University of Nottingham	Completed	No outcome recorded
Phase 4	NCT01063049	Feb 2010 → Feb 2011	—	Gastroenterology Services, Ltd.	Completed	No outcome recorded
Phase 4	NCT00889655	May 2009 → May 2010	—	Oregon Health and Science University	Unknown	No outcome recorded
Phase 4	NCT00583609	Sep 2007 → Jul 2008	constipation disorder	Braintree Laboratories	Completed	No outcome recorded
Phase 4	NCT00319670	Mar → May 2006	constipation disorder	Braintree Laboratories	Completed	No outcome recorded
Phase 4	NCT00171522	May → Sep 2005	constipation disorder	Novartis	Completed	No outcome recorded
Phase 4	NCT00153140	Jul → Oct 2004	constipation disorder	Braintree Laboratories	Completed	No outcome recorded
Phase 4	NCT00153153	Aug 2003 → Dec 2004	constipation disorder	Braintree Laboratories	Completed	No outcome recorded
Phase 4	NCT00164125	Jul 2003 → Nov 2004	constipation disorder	Braintree Laboratories	Completed	No outcome recorded
Phase 4	NCT00153114	Jan 2003 → Sep 2004	constipation disorder	Braintree Laboratories	Completed	No outcome recorded
Phase 4	NCT00153127	Nov 2001 → Sep 2004	constipation disorder	Braintree Laboratories	Completed	No outcome recorded

Phase not applicable28 trials
—	NCT07328880	Apr 2025 → Apr 2026 overdue	—	Tanta University	Recruiting	No outcome recorded
—	NCT04199026	Feb 2025 → Dec 2028 expected	sarcoma	M.D. Anderson Cancer Center	Recruiting	No outcome recorded
—	NCT06728839	Dec 2024 → Aug 2025 overdue	—	Changhai Hospital	Not yet recruiting	No outcome recorded
—	NCT06994585	Mar 2024	—	Fu Jen Catholic University Hospital	Completed	No outcome recorded
—	NCT06364111	Jan 2024 → Jun 2025	constipation disorder	Beijing Tsinghua Chang Gung Hospital	Unknown	No outcome recorded
—	NCT07557173	Jan 2024 → Jun 2026 overdue	—	Ospedale San Pio	Recruiting	No outcome recorded
—	NCT05726344	Feb → Dec 2023	—	Hospital de Clínicas Dr. Manuel Quintela	Completed	No outcome recorded
—	NCT05291325	May 2022 → Aug 2023	—	Changhai Hospital	Completed	No outcome recorded
—	NCT04434625	Jun 2020 → Feb 2021	—	Air Force Military Medical University, China	Completed	No outcome recorded
—	NCT04033250	Sep 2019 → Sep 2020	—	Rambam Health Care Campus	Unknown	No outcome recorded
—	NCT03765216	Jan → Feb 2019	—	Shandong University	Unknown	No outcome recorded
—	NCT03704571	Nov 2018 → Jul 2019	—	Shandong University	Completed	No outcome recorded
—	NCT03495804	Nov 2017 → Sep 2018	chronic thromboembolic pulmonary hypertension	Shandong University	Unknown	No outcome recorded
—	NCT03248726	Jul 2017 → Sep 2019	—	Taipei Medical University WanFang Hospital	Completed	No outcome recorded
—	NCT03142854	May → Jul 2017	—	Shandong University	Completed	No outcome recorded
—	NCT03109951	Mar 2017 → Dec 2019	type 2 diabetes mellitus	Catholic Kwandong University	Completed	No outcome recorded
—	NCT02657564	Jan 2016 → Jun 2017	acute kidney injury	Evergreen General Hospital, Taiwan	Completed	No outcome recorded
—	NCT01929668	Aug 2013 → Dec 2014	ulcerative colitis	Kyungpook National University Hospital	Completed	No outcome recorded
—	NCT01717456	Jan 2013 → Mar 2015	—	University of North Carolina, Chapel Hill	Terminated	No outcome recorded
—	NCT01452737	Nov 2011 → May 2012	—	University of British Columbia	Withdrawn	No outcome recorded
—	NCT01561248	May → Jun 2011	escherichia coli infection, hemolytic-uremic syndrome, infectious colitis, intestinal infectious disease	University Medical Center Hamburg-Eppendorf	Completed	No outcome recorded
—	NCT01518790	Sep 2010 → Aug 2011	—	Walter Reed National Military Medical Center	Completed	No outcome recorded
—	NCT01299779	Jun 2010 → May 2012	—	Thomas Jefferson University	Completed	No outcome recorded
—	NCT01610856	Mar → Jun 2010	—	University of Calgary	Completed	No outcome recorded
—	NCT01028573	Nov 2009 → Jul 2012	—	Southern California Institute for Research and Education	Unknown	No outcome recorded
—	NCT01044212	Nov 2009 → Feb 2011	intestinal disorder	University of Rochester	Completed	No outcome recorded
—	NCT00687570	Jul 2008 → Jul 2014	rectal cancer	Karolinska Institutet	Completed	No outcome recorded
—	NCT00288496	Apr 1998 → Feb 2004	—	Ikazia Hospital, Rotterdam	Completed	No outcome recorded

Also used as a comparator or background therapy in 107 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 05 trials
Phase 0	NCT07604025 Comparator	Jul 2026 → Jul 2027 expected	constipation disorder	Shaare Zedek Medical Center	Not yet recruiting	No outcome recorded
Phase 0	NCT05542810 Background	Jan → Dec 2023	—	GanHuoye	Unknown	No outcome recorded
Phase 0	NCT05277090 Background	Mar 2022	—	Yanqing Li	Unknown	No outcome recorded
Phase 0	NCT03042091 Comparator	Sep 2016 → Oct 2020	colorectal neoplasm, diverticulitis, inflammatory bowel disease	Thomas Jefferson University	Unknown	No outcome recorded
Phase 0	NCT00765557 Comparator	Dec 2007 → Jun 2014	constipation disorder	University of Texas Southwestern Medical Center	Completed	No outcome recorded
Phase 12 trials
Phase 1	NCT06393400 Background	Jan 2025 → Feb 2028 expected	pancreatic ductal adenocarcinoma	John Lenehan	Recruiting	No outcome recorded
Phase 1	NCT01243736 Comparator	Apr 2010 → Nov 2013	—	Mayo Clinic	Completed	No outcome recorded
Phase 1/22 trials
Phase 1/2	NCT02272868 Background	Jan 2015 → Oct 2016	Crohn disease	Seattle Children's Hospital	Terminated	No outcome recorded
Phase 1/2	NCT01928862 Comparator	Jun 2014 → Feb 2017	—	Ferring Pharmaceuticals	Completed	No outcome recorded
Phase 26 trials
Phase 2	NCT06503978 Background	Aug 2024 → Jul 2025 overdue	autism spectrum disorder, constipation disorder, diarrheal disease	Gut-Brain-Axis Therapeutics Inc.	Active not recruiting	No outcome recorded
Phase 2	NCT04182633 Background	Nov 2019 → Feb 2025 overdue	autism spectrum disorder, constipation disorder, diarrheal disease	Arizona State University	Active not recruiting	No outcome recorded
Phase 2	NCT03476317 Background	Jul 2018 → Dec 2020	Crohn disease	Children's Hospital of Philadelphia	Completed	No outcome recorded
Phase 2	NCT03328507 Comparator	Nov 2017 → Nov 2019	—	Braintree Laboratories	Completed	No outcome recorded
Phase 2	NCT02765256 Background	Aug 2016 → Dec 2018	Crohn disease	University of Pennsylvania	Completed	No outcome recorded
Phase 2	NCT02402270 Comparator	May 2015 → Jun 2016	—	ColonaryConcepts LLC	Completed	No outcome recorded

Phase 2/32 trials
Phase 2/3	NCT06836024 Comparator	Jun 2025 → Dec 2026 expected	constipation disorder	Hamilton Health Sciences Corporation	Not yet recruiting	No outcome recorded
Phase 2/3	NCT05341180 Comparator	May 2022 → Jul 2023	constipation disorder	All India Institute of Medical Sciences, Bhubaneswar	Completed	No outcome recorded
Phase 315 trials
Phase 3	NCT07668778 Background	Aug 2026 → Aug 2027 expected	cirrhosis of liver	Hospital do Divino Espírito Santo de Ponta Delgada	Not yet recruiting	No outcome recorded
Phase 3	NCT07277907 Comparator	Nov 2025 → Oct 2027 expected	intestinal dysmotility syndrome	Third Military Medical University	Recruiting	No outcome recorded
Phase 3	NCT02705378 Comparator	May 2017 → Apr 2019	constipation disorder	Massachusetts General Hospital	Withdrawn	No outcome recorded
Phase 3	NCT01840553 Comparator	May 2013 → Mar 2014	—	Laboratoires Mayoly Spindler	Completed	No outcome recorded
Phase 3	NCT01778192 Comparator	Jul → Nov 2012	colon adenoma, colorectal cancer	Korea University Anam Hospital	Completed	No outcome recorded
Phase 3	NCT01568814 Comparator	Jan → Mar 2012	—	Inje University	Completed	No outcome recorded
Phase 3	NCT01501513 Comparator	Dec 2011 → Mar 2013	—	Braintree Laboratories	Completed	No outcome recorded
Phase 3	NCT01415687 Comparator	May → Dec 2011	—	University of Calgary	Completed	No outcome recorded
Phase 3	NCT01267981 Comparator	Sep 2010 → Jan 2016	—	University Hospital, Brest	Completed	No outcome recorded
Phase 3	NCT01229800 Comparator	Aug → Oct 2010	—	Inje University	Completed	No outcome recorded
Phase 3	NCT01065857 Comparator	Jan → Jun 2010	—	Laboratorios Casen-Fleet S.L.U.	Completed	No outcome recorded
Phase 3	NCT00856843 Comparator	Feb → May 2009	—	Braintree Laboratories	Completed	No outcome recorded
Phase 3	NCT00756977 Comparator	Aug → Nov 2008	colon carcinoma	Braintree Laboratories	Completed	No outcome recorded
Phase 3	NCT00756548 Comparator	Aug → Nov 2008	colon carcinoma	Braintree Laboratories	Completed	No outcome recorded
Phase 3	NCT00687830 Comparator	Feb 2008 → Jul 2009	colorectal cancer	Cleveland Clinic Florida	Completed	No outcome recorded

Phase 445 trials
Phase 4	NCT07351019 Comparator	Jan → Jul 2026 overdue	colorectal cancer	Eisenhower Army Medical Center	Recruiting	No outcome recorded
Phase 4	NCT07215000 Comparator	Oct 2025 → Jan 2027 expected	colorectal cancer	Morehouse School of Medicine	Recruiting	No outcome recorded
Phase 4	NCT06825260 Comparator	Apr 2025 → Mar 2027 expected	outlet dysfunction constipation	St. Joseph's Health, New York	Recruiting	No outcome recorded
Phase 4	NCT06455813 Comparator	Oct 2024 → Jan 2027 expected	—	Odense University Hospital	Recruiting	No outcome recorded
Phase 4	NCT07605897 Comparator	Nov 2022 → Jun 2025	colorectal cancer	Joseph Spataro	Completed	No outcome recorded
Phase 4	NCT05083572 Background	Mar 2021 → Nov 2022	immune dysregulation, neurodevelopmental defects, and colitis	Changi General Hospital	Unknown	No outcome recorded
Phase 4	NCT02337413 Comparator	Jun → Jul 2020	nocturnal enuresis	Rabin Medical Center	Withdrawn	No outcome recorded
Phase 4	NCT04281667 Background	Mar 2020 → Nov 2022 overdue	necrotizing soft tissue infection, rectum adenocarcinoma	Helsinki University Central Hospital	Active not recruiting	No outcome recorded
Phase 4	NCT02336906 Comparator	Jan → Jul 2020	enuresis	Rabin Medical Center	Withdrawn	No outcome recorded
Phase 4	NCT03817788 Comparator	Apr 2019 → Apr 2020	—	Dong Yang	Completed	No outcome recorded
Phase 4	NCT03298945 Comparator	Dec 2018 → Dec 2023	colorectal cancer	VA Office of Research and Development	Completed	No outcome recorded
Phase 4	NCT03198221 Comparator	Jul 2018 → Mar 2019	—	The Cleveland Clinic	Terminated	No outcome recorded
Phase 4	NCT03319420 Comparator	Mar 2018 → Jan 2021	dry eye syndrome	Ocuwize LTD	Completed	No outcome recorded
Phase 4	NCT03148002 Comparator	Jul 2017 → Apr 2018	constipation disorder	Nova Scotia Health Authority	Completed	No outcome recorded
Phase 4	NCT03100513 Comparator	Mar 2017 → Oct 2019	hepatic encephalopathy	Tanta University	Unknown	No outcome recorded
Phase 4	NCT03060512 Comparator	Mar → Aug 2017	opioid-induced constipation	AstraZeneca	Completed	No outcome recorded
Phase 4	NCT02956057 Comparator	Nov 2016 → May 2017	—	Tomas Bata Hospital, Czech Republic	Completed	No outcome recorded
Phase 4	NCT02781493 Background	Jun 2016 → Mar 2017	—	Shandong University	Unknown	No outcome recorded
Phase 4	NCT02761213 Comparator	Apr 2016 → Aug 2017	colonic disorder	Bo-In Lee	Completed	No outcome recorded
Phase 4	NCT02547571 Comparator	Mar 2016 → Sep 2018	—	Alan Barkun	Completed	No outcome recorded
Phase 4	NCT03177434 Comparator	Feb 2016 → May 2018	constipation disorder	Children's Memorial Health Institute, Poland	Unknown	No outcome recorded
Phase 4	NCT02486536 Comparator	Jul 2015 → Jun 2017	small intestine disorder	Zhizheng Ge	Completed	No outcome recorded
Phase 4	NCT02419534 Comparator	Nov 2014 → Nov 2016	ulcer of anus and rectum	King Saud University	Unknown	No outcome recorded
Phase 4	NCT02228616 Background	Oct 2014 → Sep 2016	constipation disorder	Xian-Janssen Pharmaceutical Ltd.	Completed	No outcome recorded
Phase 4	NCT02507037 Comparator	Jul 2014 → Aug 2015	adenoma	Changhai Hospital	Completed	No outcome recorded
Phase 4	NCT02024022 Comparator	Feb 2014 → Sep 2015	—	Clinical Hospital Colentina	Completed	No outcome recorded
Phase 4	NCT01887158 Comparator	Jul 2013 → Jun 2014	intestinal cancer	Ospedale Santa Maria delle Croci	Completed	No outcome recorded
Phase 4	NCT01773096 Background	May 2013 → May 2015	constipation disorder	Shriners Hospitals for Children	Completed	No outcome recorded
Phase 4	NCT01865916 Comparator	Apr 2013 → Dec 2015	—	University of British Columbia	Completed	No outcome recorded
Phase 4	NCT01707667 Comparator	Feb → Nov 2013	constipation disorder	Shire	Completed	No outcome recorded
Phase 4	NCT04534465 Background	Feb → Mar 2013	constipation disorder	Bayer	Completed	No outcome recorded
Phase 4	NCT03279341 Comparator	Dec 2012 → Mar 2016	constipation disorder	University Hospital, Gasthuisberg	Completed	No outcome recorded
Phase 4	NCT01649674 Comparator	Nov 2011 → Dec 2024	—	National Cancer Institute, Naples	Unknown	No outcome recorded
Phase 4	NCT01510977 Comparator	Nov 2011 → Feb 2013	—	Asan Medical Center	Terminated	No outcome recorded
Phase 4	NCT01427296 Comparator	Sep 2011 → Mar 2014	—	Bausch Health Americas, Inc.	Completed	No outcome recorded
Phase 4	NCT01531140 Comparator	Nov 2010 → Nov 2011	—	Medical University of Warsaw	Completed	No outcome recorded
Phase 4	NCT01140295 Comparator	Sep 2010 → May 2011	—	Children's Hospital of Philadelphia	Terminated	No outcome recorded
Phase 4	NCT01169220 Comparator	Jul 2010 → Jan 2014	colorectal cancer	Santa Clara Valley Health & Hospital System	Completed	No outcome recorded
Phase 4	NCT01592734 Comparator	May 2010 → Nov 2011	constipation disorder, intestinal impaction	Azienda Policlinico Umberto I	Completed	No outcome recorded
Phase 4	NCT01170754 Comparator	Apr 2010 → Jul 2011	colorectal cancer	Temple University	Completed	No outcome recorded
Phase 4	NCT00953017 Comparator	Jul 2009 → May 2010	—	Brooke Army Medical Center	Completed	No outcome recorded
Phase 4	NCT00626054 Comparator	Mar 2009 → Dec 2011	colorectal cancer	Rabin Medical Center	Completed	No outcome recorded
Phase 4	NCT00677794 Comparator	Mar 2008 → Aug 2013	—	Queen's University	Completed	No outcome recorded
Phase 4	NCT00750763 Comparator	Jan → Dec 2008	—	Fremantle Hospital and Health Service	Completed	No outcome recorded
Phase 4	NCT00770432 Comparator	Nov 2007 → Jan 2008	constipation disorder	Bayer	Completed	No outcome recorded

Phase not applicable30 trials
—	NCT07426133 Background	Mar → Dec 2025	—	Shaukat Khanum Memorial Cancer Hospital & Research Centre	Completed	No outcome recorded
—	NCT06436833 Comparator	May → Nov 2024	—	Department of Medical Services Ministry of Public Health of Thailand	Unknown	No outcome recorded
—	NCT05878639 Comparator	Mar → Jul 2023	inflammatory bowel disease	Second Affiliated Hospital of Wenzhou Medical University	Completed	No outcome recorded
—	NCT05318365 Comparator	Sep 2022 → Dec 2025	BD syndrome	University of Aarhus	Unknown	No outcome recorded
—	NCT05379491 Comparator	Aug 2022 → Jun 2023	—	Zhiguo Liu	Completed	No outcome recorded
—	NCT04794049 Comparator	May → Oct 2021	colonic disorder	First People's Hospital of Hangzhou	Unknown	No outcome recorded
—	NCT04504292 Comparator	Aug 2020 → May 2021	—	University of Virginia	Unknown	No outcome recorded
—	NCT06750445 Comparator	Jan 2020 → Jun 2024	constipation disorder	Zhifeng Zhao, PhD	Completed	No outcome recorded
—	NCT03816774 Comparator	Jun 2019 → Sep 2022	colonic neoplasm, colorectal cancer	Portuguese Oncology Institute, Coimbra	Completed	No outcome recorded
—	NCT02893748 Comparator	Mar 2019	—	HyGIeaCare, Inc.	Withdrawn	No outcome recorded
—	NCT03436719 Background	Nov 2017 → Jul 2020	rectal cancer	State Scientific Centre of Coloproctology, Russian Federation	Unknown	No outcome recorded
—	NCT03011788 Comparator	Jan 2017 → Dec 2020	—	VA Connecticut Healthcare System	Unknown	No outcome recorded
—	NCT06082622 Background	Mar 2016 → Apr 2019	constipation disorder	Minia University	Completed	No outcome recorded
—	NCT02643316 Comparator	Dec 2015 → Aug 2019	—	The Cleveland Clinic	Completed	No outcome recorded
—	NCT02530346 Comparator	Oct 2015 → Dec 2019	—	Hospital Infantil de Mexico Federico Gomez	Unknown	No outcome recorded
—	NCT02540239 Comparator	Jan 2015 → Feb 2016	adenoma	Changhai Hospital	Completed	No outcome recorded
—	NCT02124447 Comparator	Jun → Aug 2014	—	Medical College of Wisconsin	Withdrawn	No outcome recorded
—	NCT01566409 Comparator	Sep 2013 → Apr 2015	constipation disorder	Line Modin	Completed	No outcome recorded
—	NCT01978509 Comparator	Sep 2013 → Mar 2019	—	Mayo Clinic	Terminated	No outcome recorded
—	NCT01923376 Comparator	Feb 2013 → Feb 2014	cirrhosis of liver, hepatic encephalopathy	New York Presbyterian Brooklyn Methodist Hospital	Withdrawn	No outcome recorded
—	NCT02009202 Comparator	Nov 2012 → Jun 2014	inflammatory bowel disease	Skane University Hospital	Completed	No outcome recorded
—	NCT01691742 Comparator	Sep 2012 → Mar 2015	constipation disorder	Duke University	Completed	No outcome recorded
—	NCT01596686 Comparator	May → Dec 2012	—	Clinical Hospital Colentina	Completed	No outcome recorded
—	NCT01533688 Comparator	Oct 2011 → Oct 2016	diabetes mellitus	University of Oklahoma	Completed	No outcome recorded
—	NCT01675739 Background	Oct 2011 → Apr 2012	—	Inje University	Completed	No outcome recorded
—	NCT01533090 Comparator	Apr → Nov 2010	inflammatory bowel disease, malignant colon neoplasm, polyp of colon	Catholic University of the Sacred Heart	Completed	No outcome recorded
—	NCT00675324 Comparator	Apr 2008 → Oct 2009	—	Karolinska Institutet	Terminated	No outcome recorded
—	NCT00558376 Comparator	Jan 2008 → Mar 2009	—	Sheba Medical Center	Terminated	No outcome recorded
—	NCT00467350 Comparator	Dec 2006 → May 2009	constipation disorder	Children's Mercy Hospital Kansas City	Terminated	No outcome recorded
—	NCT01093274 Comparator	—	—	Rabin Medical Center	Unknown	No outcome recorded

Press releases naming this drug 1 release

Date	Issuer	Release
2006-05-07	Teva Branded Pharmaceutical Products R&D, Inc.	Teva Announces Approval of Polyethylene Glycol 3350 NF for Oral Solution tevapharm.com ↗

Evidence & citations 42 cited values

Every value below carries the sentence it was read from. 230 sources stand behind the page.

Field	Value	Cited text
Known as	Polyethylene glycol	“standard bowel preparation protocol, consisting of a 2-litre split-dose polyethylene glycol (PEG) regimen combined with a one-day low-residue diet and clear liquids the...” NCT07668778 ↗ 114 “participants will be randomly assigned to receive either Polyethylene Glycol (Niflec Powder, China Chemical \& Pharmaceutical Co., Ltd., Taiwan) or Picosulfate Sodium/Citric...” NCT06994585 ↗ “At present, polyethylene glycol (PEG), owing to its good safety profile and relative lack of complications, is recommended in older patients (65 years or more), patients with...” NCT00626054 ↗ “Hospitalized adult patients were randomized to receive low volume (2 L polyethylene glycol and ascorbic acid, 2L PEG+ASC) or standard volume bowel preparation (4 L polyethylene...” PMID 41128725 ↗ Oct 2025 “Polyethyleneglycol (Muvinlax(r) or Nulytely is a non-absorbable electrolyte solution and does not induce electrolyte mucus secretion or significantly reduce fluid exchange in...” NCT06666556 ↗ “Patients will be randomized to either receive or not receive three days of polyethylene glycol (PEG, also known as MiraLAX) on the three days before surgery.” NCT05805436 ↗ “Polyethylene glycol (PEG) 3350 electrolyte solution can ensure rapid gut catharsis, which may resolve HE more effectively than lactulose.” PMID 33060437 ↗ Jan 2022 “Subjects in Group B will use a regimen with 3L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy.” NCT06728839 ↗ “Comparison of Braintree PolyethyleneGlycol(PEG) Laxative and Placebo for Relief of Constipation From Constipating Medications” NCT00153127 ↗ “Particpant take 1500ml polyethylene glycol electrolyte solution within 1.5 hours from 20 p.m the night before the examination” NCT05291325 ↗ “4 liters of polyethylene glycol plus bisacodyl 12 mg administered as rescue bowel preparation before repeat colonoscopy.” NCT07557173 ↗ “Patients will receive enteric polyethylene glycol at 100 ml/kg/dose during 4 hours, and up to 3 times, prior to surgery.” NCT02530346 ↗ “Apply the standard diet and drink 500 ml of polyethylene glycol 30 minutes after the endoscopy video-capsule ingestion.” NCT01267981 ↗ “pharmacological interventions such as oral laxatives, of which poly-ethylene glycol is the first-line drug of choice.” NCT06082622 ↗ “drinking 2-liters (8 cups) of polyethylene glycol starting at 7 p.m. the night prior to the capsule endoscopy test;” NCT01243736 ↗ “comparing sodium picosulphate and magnesium citrate versus 4-liter split-dose polyethylene glycol (PEG)” PMID 23799210 ↗ Jun 2013 “4-L polyethylene glycol preparations are effective for colon cleansing before colonoscopy.” PMID 22917636 ↗ Aug 2012 “Polyethylene glycol solution (PEG) is the most frequent laxative medication.” NCT05076799 ↗ “Mechanical Bowel Preparation using 2L polyethylene glycol (Moviprep)” NCT04281667 ↗ “Polyethylene glycol 17gm X 4 At 18h00 the day prior the colonoscopy” NCT02119000 ↗ “3 L polyethylene glycol solution combined with 2-day linaclotide” NCT05379491 ↗ “split regimen of 4 litres of polyethylene glycol (PEG) solution” NCT03816774 ↗ “Polyethylene glycol (PEG) is widely used for bowel preparation” PMID 28985630 ↗ Oct 2017 “Low-dose polyethylene glycol plus ascorbic acid (2-L PEG/Asc)” NCT02761213 ↗ “Active Ingredients; Polyethylene Glycol Propylene Glycol” NCT03319420 ↗ “low volume polyethylene glycol 2 liter one time” NCT01568814 ↗ “Polyethylene glycol-based bowel preparation” NCT03328507 ↗ “4L split polyethylene glycol solution” NCT02024022 ↗ “Oxycodone PO Polyethylene glycol” NCT03738904 ↗ “Golytely (polyethylene glycol)” NCT00953017 ↗ “polyethylene glycol” NCT01243736 ↗ “polyethylene glycol” NCT03436719 ↗ NCT04138004 ↗ NCT04458129 ↗ NCT03495804 ↗ NCT03142854 ↗ NCT06750445 ↗ NCT05726097 ↗ NCT02009202 ↗ NCT06748638 ↗ NCT04436601 ↗ NCT05083572 ↗ NCT01622972 ↗ NCT01044394 ↗ NCT04794049 ↗ NCT02507037 ↗ NCT03704571 ↗ NCT05542810 ↗ NCT04434625 ↗ NCT03315949 ↗ NCT01649674 ↗ NCT02254629 ↗ NCT05878639 ↗ NCT04199026 ↗ NCT02956057 ↗ NCT06364111 ↗ NCT01778192 ↗ NCT03100513 ↗ NCT01675739 ↗ NCT01840553 ↗ NCT02643316 ↗ NCT00687830 ↗ NCT03109951 ↗ NCT02228616 ↗ NCT03765216 ↗ NCT00288496 ↗ NCT01427296 ↗ NCT01887158 ↗ NCT01610856 ↗ NCT05277090 ↗ NCT01065857 ↗ NCT02731963 ↗ NCT02486536 ↗ NCT07328880 ↗ NCT00558376 ↗ NCT07277907 ↗ NCT01093274 ↗ NCT03042091 ↗ NCT01853709 ↗ NCT02070341 ↗ NCT07201311 ↗ NCT01229800 ↗ NCT04730245 ↗ NCT02419534 ↗ NCT01592734 ↗ NCT01533090 ↗ NCT00722410 ↗ NCT02657564 ↗ NCT07426133 ↗ NCT04033250 ↗ NCT01415687 ↗ NCT00677794 ↗ NCT02781493 ↗ NCT02359825 ↗ NCT01928862 ↗ NCT02705378 ↗ NCT02652637 ↗ NCT02893748 ↗ NCT03279341 ↗ NCT01531140 ↗ NCT01140295 ↗ NCT02979223 ↗ NCT03830489 ↗ NCT01510977 ↗ NCT06436833 ↗ NCT01865916 ↗ NCT01561248 ↗ NCT00889655 ↗ NCT03356015 ↗ NCT02396017 ↗ NCT03817788 ↗ NCT05341180 ↗ NCT03248726 ↗ NCT04534465 ↗ NCT01929668 ↗
Known as	BAY81-8430	“PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)” NCT01212445 ↗ 1 “Polyethylene glycol (MiraLAX, BAY81-8430)” NCT04534465 ↗
Known as	Colonlytely	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00750763 ↗
Known as	CTP0301-A	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05870553 ↗
Known as	Golytely	“1. Split dose 4 liter polyethylene glycol with electrolytes (PEG+E): Brand name GoLytely” NCT02124447 ↗ 18 “Subjects will be asked to take 4L of Golytely the day prior to procedure.” NCT01452737 ↗ “Polyethylene glycol 3350 - electrolyte solution (GoLYTELY)” NCT07605897 ↗ “Golytely (polyethylene glycol)” NCT00889655 ↗ “Golytely (polyethylene glycol)” NCT00953017 ↗ “Drug: Go Lytely” NCT01169220 ↗ “Drug: Golytely” NCT07215000 ↗ NCT04504292 ↗ NCT02910440 ↗ NCT03011788 ↗ NCT01533688 ↗ NCT01978509 ↗ NCT03298945 ↗ NCT01170754 ↗ NCT01169220 ↗ NCT00953017 ↗ NCT07351019 ↗ NCT07215000 ↗ NCT03198221 ↗
Known as	Golytely Oral Product	“Drug: Golytely Oral Product” NCT04504292 ↗
Known as	Laxabon	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00687570 ↗ 1 NCT00675324 ↗
Known as	Lovol-esse	“2 sachets of Lovol-esse (Polyethylene glycol) in one liter of water” NCT01887158 ↗
Known as	LVPEG-4	“Named NER1006, LVPEG-4 demonstrated clinical proof of concept and warrants further investigation.” PMID 31146679 ↗ May 2019
Known as	macrogol	“Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in” PMID 23480216 ↗ Mar 2013 1 “PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)” NCT01212445 ↗
Known as	Macrogol 3350	“macrogol 3350 59.000 g, anhydrous sodium sulphate 5.685 g, sodium bicarbonate 1.685 g, sodium chloride 1.465 g, potassium chloride 0.7425 g.” NCT03106922 ↗ 3 “One sachet consists of 13,125 gr Macrogol 3350, 178,5 mg Sodium bicarbonate, 350,7 mg Sodium chloride and 46,6 mg Potassium chloride.” NCT01429779 ↗ NCT02073552 ↗ NCT00828984 ↗
Known as	Macrogol 3350 and electrolytes	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06455813 ↗
Known as	Macrogol 4000	“3-month treatment with polyethylene glycol (Macrogol 4000), powder for oral solution, in 4g and 10g sachets.” NCT04458129 ↗
Known as	MiraLAX	“Polyethylene glycol (PEG) 3350 (MiraLax) and tegaserod (Zelnorm), a serotonin subtype 4 receptor partial agonist, are currently approved for treatment of constipation.” PMID 17573794 ↗ Jun 2007 18 “Patients will be randomized to either receive or not receive three days of polyethylene glycol (PEG, also known as MiraLAX) on the three days before surgery.” NCT05805436 ↗ “All patients will undergo intervention with taking polyethylene glycol (PEG) or Miralax (brand name) 17 grams once daily for total of 2 weeks.” NCT04210427 ↗ “Miralax at a dose of one packet (17 grams) daily may be used for constipation if unresponsive to fiber.” NCT01717456 ↗ “238g of PEG-3350 (Miralax) mixed with 2L of Gatorade consumed on the evening before colonoscopy” NCT01028573 ↗ “Polyethylene glycol (MiraLAX, BAY81-8430)” NCT04534465 ↗ “MiraLax (polyethylene glycol 3350)” NCT00889655 ↗ “Miralax 1 packet daily” NCT01044212 ↗ “Miralax (PEG 3350)” NCT00953017 ↗ NCT06503978 ↗ NCT04182633 ↗ NCT00765557 ↗ NCT02272868 ↗ NCT03800745 ↗ NCT01719653 ↗ NCT01691742 ↗ NCT01773096 ↗ NCT00953017 ↗ NCT01063049 ↗
Known as	Miralax (polyethylene glycol)	“Miralax (polyethylene glycol)” NCT01717456 ↗
Known as	Movicol	“The use of Macrogol (Movicol®) as laxative during one week prior to partial liver resection will further enhance early return of gastro-intestinal function and accelerate...” NCT01429779 ↗ 2 “PEG 3350 laxative plus electrolytes (PEG + E)/Macrogol (Movicol®, BAY81-8430)” NCT01212445 ↗ “Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol)” NCT00403858 ↗
Known as	Movicol(PEG)	“Three or four sachet of Movicol(PEG) will be dissolved in 750 ml of water and will be given over 24 hrs as 3 doses orally by mouth or Nasogastric tube and will continue up to...” NCT04436601 ↗
Known as	Moviprep	“Mechanical Bowel Preparation using 2L polyethylene glycol (Moviprep)” NCT04281667 ↗ 2 “mix four sachets of PEG (Moviprep) in 4 liters of water” NCT07328880 ↗ “MoviPrep® (PEG 3350)” NCT02402270 ↗
Known as	Muvinlax(r)	“Polyethyleneglycol (Muvinlax(r) or Nulytely is a non-absorbable electrolyte solution and does not induce electrolyte mucus secretion or significantly reduce fluid exchange in...” NCT06666556 ↗
Known as	NER1006	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01834742 ↗ 5 NCT02254486 ↗ NCT02273141 ↗ NCT02273167 ↗ NCT04708366 ↗ NCT01714466 ↗
Known as	Niflec	“PEG used in the present study was Niflec® (Meiji, Japan), which composed of macrogol 4,000 plus electrolytes” NCT04138004 ↗
Known as	Niflec Powder	“Polyethylene Glycol (Niflec Powder, China Chemical \& Pharmaceutical Co., Ltd., Taiwan)” NCT06994585 ↗
Known as	Nulytely	“Polyethyleneglycol (Muvinlax(r) or Nulytely is a non-absorbable electrolyte solution and does not induce electrolyte mucus secretion or significantly reduce fluid exchange in...” NCT06666556 ↗ 1 “NuLYTELY® (PEG 3350)” NCT02402270 ↗
Known as	PEG	“standard bowel preparation protocol, consisting of a 2-litre split-dose polyethylene glycol (PEG) regimen combined with a one-day low-residue diet and clear liquids the...” NCT07668778 ↗ 42 “At present, polyethylene glycol (PEG), owing to its good safety profile and relative lack of complications, is recommended in older patients (65 years or more), patients with...” NCT00626054 ↗ “Safety of polyethylene glycol (PEG) formulations has been validated in several studies, it presents little severe side effects and the advantage of its applicability to...” NCT05726344 ↗ “Polyethylene glycol (PEG) is a hydrophilic compound that enhances the fusion of the lipid bilayer membrane of severed axons, restoring the nerve's immediate ability to conduct...” NCT05897086 ↗ “The objective of this study was to compare the bowel preparation efficacy of picosulfate/magnesium citrate (PMC) vs polyethylene glycol (PEG) in a one-day vs two-day split dose regimen.” PMID 30921345 ↗ Mar 2019 “Two bowel preparation regimens of Polyethylene Glycol (PEG), commonly referred to as "Golytely" will be tested for their efficacy (bowel cleansing effect) and patient tolerability.” NCT00687830 ↗ “Patients will be randomized to either receive or not receive three days of polyethylene glycol (PEG, also known as MiraLAX) on the three days before surgery.” NCT05805436 ↗ “After standard BP of split-dose polyethylene glycol (PEG) was completed, patients were randomized (1:1) to the individualized group or standard group.” PMID 37735023 ↗ Sep 2023 “All patients will undergo intervention with taking polyethylene glycol (PEG) or Miralax (brand name) 17 grams once daily for total of 2 weeks.” NCT04210427 ↗ “Polyethylene glycol (PEG) is in a class of medications called osmotic laxatives which works by causing water to be retained with the stool.” NCT04436601 ↗ “Polyethylene glycol (PEG) 3350 electrolyte solution can ensure rapid gut catharsis, which may resolve HE more effectively than lactulose.” PMID 33060437 ↗ Jan 2022 “The aim of this study was to identify the optimal dose and timing of polyethylene glycol (PEG) for small bowel preparation before VCE.” PMID 31682026 ↗ Dec 2019 “no trial has investigated the effect of gum chewing on bowel preparation for colonoscopy in addition to polyethylene glycol (PEG).” PMID 27327849 ↗ Jun 2016 “The experimental arm will take 4 L polyethylene glycol solution (PEG) in split dose plus bisacodyl and 3 days of fiber-free diet” NCT03830489 ↗ “Comparison of Braintree PolyethyleneGlycol(PEG) Laxative and Placebo for Relief of Constipation From Constipating Medications” NCT00153127 ↗ “the Lct + 3 L polyethylene glycol (PEG) group (group A), the 3 L PEG group (group B), or the Lct + 2 L PEG group (group C)” PMID 40423516 ↗ May 2025 “Participants in Group A and Low risk patients in group B are given standard regimen: 2 L Polyethylene Glycol (PEG) regimen” NCT03765216 ↗ “This study aimed to assess the impact of the dose of Polyethylene Glycol(PEG) on the quality of bowel preparation.” NCT03356015 ↗ “Polyethylene glycol (PEG) is the most commonly used bowel cleansing agent for colonoscopy in the world.” NCT02657564 ↗ “Polyethylene glycol 3350 (PEG) will be used within it's FDA indication and dosing for constipation.” NCT06159777 ↗ “Polyethylene glycol (PEG) for bowel cleansing still had up to 10 % unprepared colon.” PMID 27864718 ↗ Nov 2016 “either polyethylene glycol (PEG) or sodium picosulphate (NaPico) (primary outcome)” PMID 26360658 ↗ Mar 2016 “Polyethylene glycol solution (PEG) is the most frequent laxative medication.” NCT05076799 ↗ “polyethylene glycol solution (PEG split dose (1 L + 2 L) plus linaclotide” NCT05379491 ↗ “polyethylene glycol (PEG, 10 g) was provided as rescue medication.” NCT06750445 ↗ “split regimen of 4 litres of polyethylene glycol (PEG) solution” NCT03816774 ↗ “Polyethylene glycol (PEG) is widely used for bowel preparation” PMID 28985630 ↗ Oct 2017 “Oral polyethylene glycol (PEG) based preparation (9-12 years)” NCT01928862 ↗ “15 mg bisacodyl plus 2 L polyethylene glycol [PEG] solution” PMID 25910064 ↗ Apr 2015 “2 L of polyethylene glycol (PEG) the evening before” PMID 27451294 ↗ Jul 2016 “Polyethylene Glycol （PEG）：Heshuang, 137.15g/ bag ，” NCT06748638 ↗ “neomycin, metronidazole, polyethylene glycol (PEG)” NCT02652637 ↗ “PEG/electrolytes 1L/1L Polyethylene glycol 17gm” NCT02119000 ↗ “Polyethylene Glycol (PEG) and 15 mg Bisacodyl” NCT01865916 ↗ “using a polyethylene glycol (PEG) solution.” PMID 24312709 ↗ Aug 2013 “polyethylene glycole (PEG) solution” NCT01649674 ↗ “Drug: Polyethylene glycol (PEG)” NCT02228616 ↗ “Polyethylene glycol (PEG)” NCT01853709 ↗ “polyethylene glycol (PEG)” NCT02893748 ↗ “polyethylene glycol (PEG)” NCT01533090 ↗ “polyethylene glycol (PEG)” NCT01675739 ↗ “Polyethylene Glycol (PEG)” NCT03142854 ↗ “Polyethylene Glycol (PEG)” NCT04794049 ↗
Known as	PEG + E	“OBJECTIVES: To assess the efficacy of polyethylene glycol 3350 plus electrolytes (PEG + E; Movicol) as oral monotherapy in the treatment of faecal impaction in children, and to...” PMID 16819379 ↗ Jul 2006 1 NCT02124447 ↗
Known as	PEG 3350	“Polyethylene glycol (PEG) 3350 (MiraLax) and tegaserod (Zelnorm), a serotonin subtype 4 receptor partial agonist, are currently approved for treatment of constipation.” PMID 17573794 ↗ Jun 2007 28 “Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g” NCT02540031 ↗ “Eligible subjects ≥ 17 years of age were randomized to receive either placebo or PEG 3350 17 g once daily in this multicenter, double-blind trial.” PMID 27158544 ↗ May 2016 “Polyethylene glycol (PEG) 3350 electrolyte solution can ensure rapid gut catharsis, which may resolve HE more effectively than lactulose.” PMID 33060437 ↗ Jan 2022 “238g of PEG-3350 (Miralax) mixed with 2L of Gatorade consumed on the evening before colonoscopy” NCT01028573 ↗ “This study will evaluate the safety and efficacy of PEG 3350 for use in nerve repair.” NCT03236064 ↗ “Subjects will be asked to take 4L of PEG-3350 solution the day prior to procedure.” NCT02290093 ↗ “a laxative, polyethylene glycol 3350 (PEG-3350) taken with 4 liters of water.” NCT07605897 ↗ “Polyethylene Glycol 3350 Powder for Solution (PEG 3350)” NCT02292459 ↗ “with PEG-3350 119 gram bottle (labeled #1)” NCT01299779 ↗ “ECP (PEG 3350) Colon Prep Kit” NCT03332485 ↗ “Miralax (PEG 3350)” NCT00953017 ↗ NCT01707667 ↗ NCT07604025 ↗ NCT06836024 ↗ NCT00467350 ↗ NCT01212445 ↗ NCT06393400 ↗ NCT02402270 ↗ NCT00583609 ↗ NCT01170754 ↗ NCT00868985 ↗ NCT01501513 ↗ NCT03957668 ↗ NCT01251822 ↗ NCT01929590 ↗ NCT03742232 ↗ NCT05821309 ↗ NCT03987893 ↗
Known as	PEG 3350 with electrolytes	“split-dose (PEG) 3350 with electrolytes (GoLytely; Braintree Laboratories, Inc, Braintree, MA)” PMID 21115134 ↗ Nov 2010
Known as	PEG 3350+E	“Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in” PMID 23480216 ↗ Mar 2013
Known as	PEG-EL	“reference PEG-electrolyte (PEG-EL) formulation” PMID 23152962 ↗ Nov 2012
Known as	PEG-ELS	“polyethylene glycol (PEG-ELS) and bisacodyl tablets” NCT01044394 ↗
Known as	PEG-ELS-(GoLytely)	“4 liters of polyethylene glycol electrolyte lavage solution (PEG-ELS-(GoLytely))+ placebo given the evening prior to the colonoscopy” NCT01533688 ↗
Known as	PGE + E	“Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.” PMID 16819379 ↗ Jul 2006
Known as	Polyethylene glycol (PEG)	“subjects taking 1 of 3 single doses of Polyethylene Glycol (PEG) plus Electrolytes (PEG+E)” NCT01212445 ↗ 1 “Polyethylene glycol (PEG)” NCT02705378 ↗
Known as	polyethylene glycol (PEG) 3350	“This study is to compare the efficacy and safety of polyethylene glycol (PEG) 3350 with that of prucalopride in the treatment of chronic constipation in females.” NCT01251822 ↗
Known as	polyethylene glycol 3350	“This multicenter, double-blind, placebo-controlled, parallel-group trial included adults with chronic idiopathic constipation randomized to polyethylene glycol 3350 17 g...” PMID 36120087 ↗ Sep 2022 44 “OBJECTIVES: The aim of this study was to compare the clinical efficacy and tolerance of polyethylene glycol 3350 (PEG) and lactulose for the treatment of functional...” PMID 30383579 ↗ Mar 2019 “This randomized phase II trial studies how well macrogol 3350-based oral osmotic laxative (polyethylene glycol 3350) works in preventing cancer in patients at risk of colorectal cancer.” NCT00828984 ↗ “To evaluate patient acceptance of a new MiraLax dose formulation in children currently treated with polyethylene glycol 3350 powder for treatment of constipation.” NCT00319670 ↗ “oral treatment consistent with rifaximin 200 mg three times a day for 7 days and polyethylene glycol-3350, 17 gr per day in water for 10 days” NCT04730245 ↗ “Two common treatments are polyethylene glycol 3350 (PEG), an osmotic laxative, and Senna, a plant-based stimulant laxative.” NCT07604025 ↗ “Polyethylene Glycol 3350 17g should be mixed in 8 ounces of fluid for administration.” NCT04197869 ↗ “Patients will receive the Protocol with Polyethylene Glycol 3350.” NCT03148002 ↗ “PEG 3350 (polyethylene glycol 3350)” NCT03957668 ↗ NCT01566409 ↗ NCT02336906 ↗ NCT07605897 ↗ NCT00153114 ↗ NCT02337413 ↗ NCT00153127 ↗ NCT00153153 ↗ NCT01923376 ↗ NCT06159777 ↗ NCT05726344 ↗ NCT00756548 ↗ NCT02765256 ↗ NCT00756977 ↗ NCT00164125 ↗ NCT03476317 ↗ NCT05897086 ↗ NCT00770432 ↗ NCT00403819 ↗ NCT07700277 ↗ NCT04585542 ↗ NCT04210427 ↗ NCT04263896 ↗ NCT00171522 ↗ NCT00403897 ↗ NCT00403858 ↗ NCT00856843 ↗ NCT03060512 ↗ NCT01518790 ↗ NCT02292459 ↗ NCT00503607 ↗ NCT00503815 ↗ NCT05805436 ↗ NCT00889655 ↗ NCT05318365 ↗ NCT06825260 ↗ NCT04270019 ↗
Known as	polyethylene glycol electrolyte lavage solution	“Golytely (polyethylene glycol electrolyte lavage solution) and placebo” NCT01533688 ↗
Known as	Polyethylene glycol: Fortrans	“Polyethylene glycol: Fortrans” NCT01531140 ↗
Known as	polyethylene glycole	“polyethylene glycole (PEG) solution” NCT01649674 ↗
Known as	polyethylenglycol	“oral laxatives (polyethylenglycol at 100 ml/kg/dose for up to 3 times) and stoma enemas (20mlkgdo of normal saline 3 times a day) will be prescribed” NCT02530346 ↗
Known as	Selg-esse 1000	“2 envelopes of Selg-esse 1000 (polyethylene glycol) in 2 litres of water” NCT01887158 ↗
Modality	Other / unclassified	“five new low-volume PEG-based bowel preparations (LVPEG) were tested for clinical proof of concept.” PMID 31146679 ↗ May 2019
Route	Oral	“It allows a single orally administered laxative to be used for disimpaction without recourse to invasive interventions.” PMID 16819379 ↗ Jul 2006